MyMatrixx Partnering with you to help injured workers on their path to recovery.Powerful, affordable pharmacy solutions for your workers' compensation program.Strong today.Stronger tomorrow.Strongest together. New Branding, Same MyMatrixx PromiseLEARN MORE News May 4, 2026 The Industry Continues to Choose MyMatrixx as the #1 PBM October 28, 2024 The Industry Ranks MyMatrixx the #1 PBM (Again) October 2, 2024 Adam Fowler joins MyMatrixx to lead Regulatory Affairs September 6, 2024 Connect with MyMatrixx at NWCDC 2024 July 9, 2024 Connect with MyMatrixx at #WCI2024 Read more Blogs May 4, 2026 High-Cost Generic Drugs: A Pharmacy Oxymoron and Other Emerging Medication Trends April 6, 2026 The AI Confidence Gap: Why Workers' Compensation Leaders Need Better Governance Before Deployment April 6, 2026 Cliff Belliveau: Putting AI in Action, Intelligently – Part 2 April 6, 2026 Cliff Belliveau: Putting AI in Action, Intelligently – Part 1 April 6, 2026 Supporting Today’s Adjuster With Technology That Works Smarter Read more PharmaWatch May 7, 2026 Federal marijuana rescheduling process advances April 8, 2026 FDA approves Foundayo™ for Chronic Weight Management April 8, 2026 California DWC Announces Updates to MTUS Drug Formulary March 27, 2026 New ODG formulary updates two N drugs to Y drugs, effective April 3, 2026 February 19, 2026 Ozempic® recognized as proprietary semaglutide treatment for diabetes replacing Rybelsus® The Industry Ranks MyMatrixx the #1 PBM (Again)For the 4th straight year in a row, MyMatrixx has earned the title of best workers’ compensation PBM in CompPharma’s Annual Survey Report.LEARN MORE INFOGRAPHIC: Addressing a Growing Pain Point in Workers' Compensation Learn how our One Drug Review is your remedy and cost saver for topicalsDOWNLOAD NOW
April 6, 2026 The AI Confidence Gap: Why Workers' Compensation Leaders Need Better Governance Before Deployment
February 19, 2026 Ozempic® recognized as proprietary semaglutide treatment for diabetes replacing Rybelsus®
